MAPT and Alzheimer disease: We set out to test the hypothesis that Aß and Tau trigger distinct but overlapping responses in astrocytes, identifying the induction of both putative deleterious and adaptive-protective signatures, the latter of which is able to attenuate these AD-relevant pathologies if pre-emptively activated.